US Stock MarketDetailed Quotes

OCUP Ocuphire Pharma

Watchlist
  • 1.990
  • +0.140+7.57%
Close May 3 16:00 ET
  • 1.940
  • -0.050-2.51%
Post 19:17 ET
50.96MMarket Cap-4326P/E (TTM)

About Ocuphire Pharma Company

Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.

Company Profile

SymbolOCUP
Company NameOcuphire Pharma
Founded2018
CEODr. George Magrath, PhD
MarketNASDAQ
Employees14
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address37000 Grand River Avenue,Suite 120
CityFarmington Hills
ProvinceMichigan
CountryUnited States of America
Zip Code48335
Phone1-248-681-9815
Websitehttp://www.ocuphire.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. George Magrath, PhD
  • Director and Chief Executive Officer
  • 2.67M
  • Nirav Jhaveri, C.F.A.,M.B.A.
  • Chief Financial Officer
  • --
  • Dr. Ashwath Jayagopal, PhD
  • Chief Scientific and Development Officer
  • --
  • Joseph K. Schachle
  • Chief Operating Officer
  • --
  • Amy Rabourn
  • Senior Vice President, Finance and Principal Accounting Officer
  • 789.92K
  • Bernhard Hoffmann
  • Senior Vice President, Corporate Development
  • 789.92K
  • Cam S. Gallagher
  • Chairman of the Board
  • 174.62K
  • Jay Pepose
  • Independent Director
  • 662.10K
  • Susan K. Benton
  • Independent Director
  • 135.34K
  • Dr. James S.J. Manuso,PhD
  • Independent Director
  • 154.81K
  • Sean Ainsworth
  • Lead Independent Director
  • 149.56K
  • Richard J. Rodgers
  • Independent Director
  • 899.08K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg